Plain-English translation of NCT06232213 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This trial is testing a new approach called the PTC microtumor model to help treat people with ovarian or endometrial cancer that has come back or stopped responding to standard chemotherapy drugs. The model works by growing your own cancer cells in the lab and testing different drugs against them to see which ones work best for your specific tumor. The goal is to help doctors choose personalized treatment that's more likely to be effective for you.
When gynecological cancers come back or become resistant to chemotherapy, it's very difficult to know which drugs to try next. This trial exists to see if testing your cancer cells in the lab can accurately predict which treatments will actually work for your cancer, potentially leading to better outcomes than traditional trial-and-error approaches.
You likely qualify if…
You likely don't qualify if…
If you join this study, doctors will collect tumor tissue or fluid samples from you, which will be sent to a lab where your cancer cells are grown and tested against different drugs to see which ones are most effective. You will then be treated based on these lab results, and your response to treatment will be carefully tracked using standard cancer response measurements. Your progress will be compared to a group of similar patients who received standard treatment selection without the lab testing.
AI-generated summary from trial data · Jun 4, 2026 · Not medical advice
China